HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression and regulation of toll-like receptors (TLRs) in human intervertebral disc cells.

AbstractPURPOSE:
Although inflammatory processes play an essential role in painful intervertebral disc (IVD) degeneration, the underlying regulatory mechanisms are not well understood. This study was designed to investigate the expression, regulation and importance of specific toll-like receptors (TLRs)--which have been shown to play an essential role e.g. in osteoarthritis--during degenerative disc disease.
METHODS:
The expression of TLRs in human IVDs was measured in isolated cells as well as in normal or degenerated IVD tissue. The role of IL-1β or TNF-α in regulating TLRs (expression/activation) as well as in regulating activity of down-stream pathways (NF-κB) and expression of inflammation-related genes (IL-6, IL-8, HSP60, HSP70, HMGB1) was analyzed.
RESULTS:
Expression of TLR1/2/3/4/5/6/9/10 was detected in isolated human IVD cells, with TLR1/2/4/6 being dependent on the degree of IVD degeneration. Stimulation with IL-1β or TNF-α moderately increased TLR1/TLR4 mRNA expression (TNF-α only), and strongly increased TLR2 mRNA expression (IL-1β/TNF-α), with the latter being confirmed on the protein level. Stimulation with IL-1β, TNF-α or Pam3CSK4 (a TLR2-ligand) stimulated IL-6 and IL-8, which was inhibited by a TLR2 neutralizing antibody for Pam3CSK4; IL-1β and TNF-α caused NF-κB activation. HSP60, HSP70 and HMGB1 did not increase IL-6 or IL-8 and were not regulated by IL-1β/TNF-α.
CONCLUSION:
We provide evidence that several TLRs are expressed in human IVD cells, with TLR2 possibly playing the most crucial role. As TLRs mediate catabolic and inflammatory processes, increased levels of TLRs may lead to aggravated disc degeneration, chronic inflammation and pain development. Especially with the identification of more endogenous TLR ligands, targeting these receptors may hold therapeutic promise.
AuthorsMarina Klawitter, Michiyuki Hakozaki, Hiroshi Kobayashi, Olga Krupkova, Lilian Quero, Caroline Ospelt, Steffen Gay, Oliver Hausmann, Thomas Liebscher, Ullrich Meier, Miho Sekiguchi, Shin-ichi Konno, Norbert Boos, Stephen J Ferguson, Karin Wuertz
JournalEuropean spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society (Eur Spine J) Vol. 23 Issue 9 Pg. 1878-91 (Sep 2014) ISSN: 1432-0932 [Electronic] Germany
PMID24997157 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CXCL8 protein, human
  • Chaperonin 60
  • HMGB1 Protein
  • HMGB1 protein, human
  • HSP70 Heat-Shock Proteins
  • HSPD1 protein, human
  • IL6 protein, human
  • Inflammation Mediators
  • Interleukin-1beta
  • Interleukin-6
  • Interleukin-8
  • Lipopeptides
  • Mitochondrial Proteins
  • NF-kappa B
  • Pam(3)CSK(4) peptide
  • Toll-Like Receptors
  • Tumor Necrosis Factor-alpha
Topics
  • Cells, Cultured
  • Chaperonin 60 (genetics)
  • Gene Expression Regulation (drug effects, immunology)
  • HMGB1 Protein (genetics)
  • HSP70 Heat-Shock Proteins (genetics)
  • Humans
  • Inflammation Mediators (pharmacology)
  • Interleukin-1beta (pharmacology)
  • Interleukin-6 (genetics)
  • Interleukin-8 (genetics)
  • Intervertebral Disc (cytology, immunology, physiology)
  • Intervertebral Disc Degeneration (genetics, immunology, pathology)
  • Lipopeptides (pharmacology)
  • Mitochondrial Proteins (genetics)
  • NF-kappa B (genetics)
  • Osteoarthritis (immunology, pathology, physiopathology)
  • Toll-Like Receptors (genetics, immunology)
  • Tumor Necrosis Factor-alpha (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: